Kiyoshi Ohkawa[Author] - Search Results

Year	Number of Results
2002	2
2003	3
2004	4
2005	1
2006	2
2007	7
2008	3
2009	1
2010	3
2011	3
2012	2
2014	1
2015	2
2017	1
2018	2
2019	1
2023	0

1

Chemotherapeutic agents that induce mitochondrial apoptosis.

Asakura T, Ohkawa K. Asakura T, et al. Among authors: ohkawa k. Curr Cancer Drug Targets. 2004 Nov;4(7):577-90. doi: 10.2174/1568009043332772. Curr Cancer Drug Targets. 2004. PMID: 15578915 Review.

2

Transplantation of liver organoids in the omentum and kidney.

Saito R, Ishii Y, Ito R, Nagatsuma K, Tanaka K, Saito M, Maehashi H, Nomoto H, Ohkawa K, Mano H, Aizawa M, Hano H, Yanaga K, Matsuura T. Saito R, et al. Among authors: ohkawa k. Artif Organs. 2011 Jan;35(1):80-3. doi: 10.1111/j.1525-1594.2010.01049.x. Epub 2010 Oct 14. Artif Organs. 2011. PMID: 20946288

3

Chemotherapeutic Effect of CD147 Antibody-labeled Micelles Encapsulating Doxorubicin Conjugate Targeting CD147-Expressing Carcinoma Cells.

Asakura T, Yokoyama M, Shiraishi K, Aoki K, Ohkawa K. Asakura T, et al. Among authors: ohkawa k. Anticancer Res. 2018 Mar;38(3):1311-1316. doi: 10.21873/anticanres.12353. Anticancer Res. 2018. PMID: 29491054

4

FGF-2 signaling induces downregulation of TAZ protein in osteoblastic MC3T3-E1 cells.

Eda H, Aoki K, Marumo K, Fujii K, Ohkawa K. Eda H, et al. Among authors: ohkawa k. Biochem Biophys Res Commun. 2008 Feb 8;366(2):471-5. doi: 10.1016/j.bbrc.2007.11.140. Epub 2007 Dec 5. Biochem Biophys Res Commun. 2008. PMID: 18067853

5

Extracorporeal bioartificial liver using the radial-flow bioreactor in treatment of fatal experimental hepatic encephalopathy.

Kanai H, Marushima H, Kimura N, Iwaki T, Saito M, Maehashi H, Shimizu K, Muto M, Masaki T, Ohkawa K, Yokoyama K, Nakayama M, Harada T, Hano H, Hataba Y, Fukuda T, Nakamura M, Totsuka N, Ishikawa S, Unemura Y, Ishii Y, Yanaga K, Matsuura T. Kanai H, et al. Among authors: ohkawa k. Artif Organs. 2007 Feb;31(2):148-51. doi: 10.1111/j.1525-1594.2007.00354.x. Artif Organs. 2007. PMID: 17298404

6

Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1.

Asakura T, Yamaguchi N, Ohkawa K, Yoshida K. Asakura T, et al. Among authors: ohkawa k. Int J Oncol. 2015 May;46(5):2251-60. doi: 10.3892/ijo.2015.2916. Epub 2015 Mar 4. Int J Oncol. 2015. PMID: 25738863

7

Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma.

Iida Y, Aoki K, Asakura T, Ueda K, Yanaihara N, Takakura S, Yamada K, Okamoto A, Tanaka T, Ohkawa K. Iida Y, et al. Among authors: ohkawa k. Int J Oncol. 2012 Jun;40(6):2122-30. doi: 10.3892/ijo.2012.1406. Epub 2012 Mar 19. Int J Oncol. 2012. PMID: 22447231

8

Three-dimensional culture promotes reconstitution of the tumor-specific hypoxic microenvironment under TGFβ stimulation.

Marushima H, Shibata S, Asakura T, Matsuura T, Maehashi H, Ishii Y, Eda H, Aoki K, Iida Y, Morikawa T, Ohkawa K. Marushima H, et al. Among authors: ohkawa k. Int J Oncol. 2011 Nov;39(5):1327-36. doi: 10.3892/ijo.2011.1142. Epub 2011 Jul 22. Int J Oncol. 2011. PMID: 21785823

9

An efficient system for secretory production of fibrinogen using a hepatocellular carcinoma cell line.

Matsumoto M, Matsuura T, Aoki K, Maehashi H, Iwamoto T, Ohkawa K, Yoshida K, Yanaga K, Takada K. Matsumoto M, et al. Among authors: ohkawa k. Hepatol Res. 2015 Mar;45(3):315-25. doi: 10.1111/hepr.12353. Epub 2014 Jun 3. Hepatol Res. 2015. PMID: 24802089

10

Target chemotherapy of anti-CD147 antibody-labeled liposome encapsulated GSH-DXR conjugate on CD147 highly expressed carcinoma cells.

Matsudaira H, Asakura T, Aoki K, Searashi Y, Matsuura T, Nakajima H, Tajiri H, Ohkawa K. Matsudaira H, et al. Among authors: ohkawa k. Int J Oncol. 2010 Jan;36(1):77-83. Int J Oncol. 2010. PMID: 19956835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results